ASX Equity Snapshot
CU6 Weekly Equity Report
Clarity Pharmaceuticals Ltd
What the company does
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, …
What the weekly tape is saying
CU6 closed the latest completed week at 2.15 AUD. The 4-week return is -25.9% and the 12-week return is -37.1%. Trend Signal is inactive, Market Dynamics is -1.23. Setup signature: Risk-first tape with a 12/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3.17 AUD
- Vs Trend Line
- -32.1%
- Fair Value
- 3.41 AUD
- Vs Fair Value
- -37.0%
- 52W High
- 5.87 AUD
- 52W Low
- 1.97 AUD
- Drawdown
- -63.4%
- Range Position
- 4.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 16
- 52W Active Breadth
- 30.8%
- Sector Scope
- AU Healthcare
- Sector Rank
- 93 of 146
- Sector Percentile
- 36.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AU Healthcare
- Tracked Peers
- 100
- 4W Rank
- 92 of 100
- Avg 1W
- -1.4%
- Avg 4W
- -3.6%
- Trend Breadth
- 15.0%
- Positive MD
- 39.0%
AU Biotechnology
- Tracked Peers
- 47
- 4W Rank
- 43 of 47
- Avg 1W
- -0.1%
- Avg 4W
- -5.8%
- Trend Breadth
- 10.6%
- Positive RS
- 21.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.23
- 4W MD Change
- -245.3%
- Relative Strength
- -37.72
- 4W RS Change
- -169.3%
- Expectation
- Undecided
- Probability
- 48.33%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 12.1M
- 13W Average
- 11.4M
- 52W Average
- 12.9M
- Vs 13W
- 1.1x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.7%
- 52W Volatility
- 11.5%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 9.5% / -7.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- ASX
- Country
- AU
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- AUD
- Market Cap
- 928.7M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.15 AUD | -4.4% | 3.17 AUD | 3.41 AUD | -1.23 | -37.72 | 12.1M | Off |
| 5 Jun 2026 | 2.25 AUD | -9.6% | 3.22 AUD | 3.40 AUD | -1.02 | -33.50 | 11.5M | Off |
| 29 May 2026 | 2.49 AUD | -9.1% | 3.30 AUD | 3.39 AUD | -0.75 | -27.31 | 11.7M | Off |
| 22 May 2026 | 2.74 AUD | -5.5% | 3.38 AUD | 3.38 AUD | -0.51 | -19.21 | 11.4M | Off |
| 15 May 2026 | 2.90 AUD | -0.3% | 3.44 AUD | 3.37 AUD | -0.36 | -14.01 | 7.6M | Off |
| 8 May 2026 | 2.91 AUD | 0.3% | 3.50 AUD | 3.35 AUD | -0.17 | -14.68 | 12.3M | Off |
| 1 May 2026 | 2.90 AUD | -1.4% | 3.60 AUD | 3.34 AUD | -0.20 | -14.67 | 10.9M | Off |
| 24 Apr 2026 | 2.94 AUD | -6.1% | 3.67 AUD | 3.33 AUD | -0.14 | -13.98 | 12.3M | Off |
| 17 Apr 2026 | 3.13 AUD | -1.6% | 3.70 AUD | 3.31 AUD | -0.07 | -9.85 | 21.6M | Off |
| 10 Apr 2026 | 3.18 AUD | 1.0% | 3.72 AUD | 3.30 AUD | -0.02 | -8.07 | 6.2M | Off |
| 3 Apr 2026 | 3.15 AUD | -3.7% | 3.72 AUD | 3.28 AUD | 0.24 | -4.20 | 8.6M | Off |
| 27 Mar 2026 | 3.27 AUD | -4.4% | 3.72 AUD | 3.27 AUD | 0.29 | 0.93 | 10.1M | Off |
| 20 Mar 2026 | 3.42 AUD | -10.7% | 3.71 AUD | 3.25 AUD | 0.30 | 7.24 | 12.2M | Off |
| 13 Mar 2026 | 3.83 AUD | 7.0% | 3.71 AUD | 3.23 AUD | 0.24 | 17.79 | 9.6M | Off |